← All companies

OBX

Obsidian Therapeutics, Inc.

OBX Pharmaceutical Preparations EDGAR ↗

—

—

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

—

Recent SEC filings

20 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Unregistered sale of equity; Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Aug 3, 2026

Other filings

3 Aug 3, 2026 3 Aug 3, 2026 3 Aug 3, 2026 3 Aug 3, 2026 3 Aug 3, 2026 3 Aug 3, 2026 3 Aug 3, 2026 3 Aug 3, 2026 S-8 Aug 3, 2026 CERT Aug 3, 2026 8-A12B/A Aug 3, 2026 8-A12B Aug 3, 2026 EFFECT Jul 2, 2026 424B3 Jul 2, 2026 S-4/A Jul 2, 2026 S-4/A S-4/A NO. 3 Jun 30, 2026 S-4/A S-4/A NO. 2 Jun 24, 2026 S-4/A Jun 2, 2026 S-4 Apr 22, 2026